Revenue

With a new commercial chief and a major licensed spectrum rollout, GeoLinks is poised to challenge broadband incumbents in key Southwestern markets.

GIBO Holdings unveils a next-gen AI engine for mass content production, but a plunging stock price reveals deep market skepticism about its high-stakes plan.

As Canada launches a bold defence strategy, drone-maker Draganfly recruits a former top general to navigate the multi-billion dollar opportunity.

The Quebec firm improved its score, setting a new benchmark for ESG performance in a competitive industry increasingly focused on responsible practices.

An Orlando startup is using AI for 10-second quotes and escrow payments, aiming to fix a market plagued by delays and a severe skilled labor shortage.

India's largest newspaper group wins a top CSR award, but it's the citizen-led campaigns behind the win that reveal a new model for media's social impact.

New data reveals a targeted therapy can help patients with a rare, aggressive lung cancer even after their disease shows signs of worsening.

With AI expert Zack Kass headlining, Scale Computing's upcoming summit aims to redefine edge infrastructure, challenging traditional distributed IT models.

A new $175M Indiana facility from a Kratos-RAFAEL venture breaks ground, aiming to fix a critical national security vulnerability in U.S. rocket motor production.

With most enterprise AI projects failing, TQA expands its partnerships with Microsoft and ServiceNow to move AI from experimentation to real-world impact.

With its NAD+ technology featured in Forbes, biotech brand Aramore is challenging marketing hype with scientific rigor and a vision for longevity.

BitGo and New Frontier Labs are launching FYUSD, a stablecoin bringing U.S. regulatory standards to Asia and paving the way for AI-driven finance.

As MARA preps its Q4 earnings call, investors look beyond Bitcoin to see if its ambitious digital energy and AI infrastructure strategy is paying off.

After a period of uncertainty, the digital asset firm has regained compliance with Nasdaq's bid price rule, a key step for its institutional ambitions.

As Home Instead names its 10 Care Pros of the Year, the awards highlight both profound human compassion and the urgent need to address a critical caregiver shortage.

Singapore's Strutt Inc. sees unprecedented demand for its ev¹ Smart Everyday Vehicle. Now, the company faces the ultimate test: scaling up to deliver.

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

F&G Annuities & Life declared its quarterly dividend, offering a sign of stability even as a recent earnings report and stock drop raise questions.

With its Felix AI assistant, Syncx is accelerating locums staffing with faster placements and risk assessment to combat a critical healthcare shortage.